Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inmed Pharmaceuticals Inc (NQ: INM ) 0.2700 UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Inmed Pharmaceuticals Inc < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Bhang CEO Resigns, Michigan's Top Cannabis Industry Regulator Leaves For New Job At LARA & More Leadership Changes August 11, 2022 As Benzinga Cannabis Capital Conference returns on September 13-14 to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the... Via Benzinga BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Board Appointment, Changes August 09, 2022 Via Investor Brand Network BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on Phase 2 EB Trial July 25, 2022 Via Investor Brand Network InMed Provides An Update On Phase 2 Clinical Trial Investigating Cannabinol Cream For Epidermolysis Bullosa July 25, 2022 InMed Pharmaceuticals Inc. (NASDAQ: INM) provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment Via Benzinga BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Michael Woudenberg as Chief Operating Officer July 18, 2022 Via Investor Brand Network Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday July 18, 2022 Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering... Via Benzinga Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session July 15, 2022 Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday July 15, 2022 Good morning! We're starting the last day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! Via InvestorPlace Why Is Pinterest Higher By 14%? 20 Stocks Moving In Friday's Pre-Market Session July 15, 2022 Gainers United Maritime Corporation (NASDAQ: USEA) rose 55% to $3.41 in pre-market trading. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on... Via Benzinga BayMedica LLC: Working With Cannabis Multi-State Operators To Make Their Products Better July 05, 2022 InMed Pharmaceuticals Inc. (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is taking a leading position in the marketplace. Via Benzinga Marijuana As An Appetite Suppressant? It's A Possibility June 30, 2022 Using cannabis as an appetite suppressant for weight management may seem counterintuitive, but one rare cannabinoid may have just that effect. Delta-9 (d-9)-dominant tetrahydrocannabivarin (THCV) has... Via Benzinga InMed Pharmaceuticals: The Clinical-Stage Company Setting Sites On Dominating Rare Cannabinoid Production And Commercialization Across Global Markets June 23, 2022 Shane Johnson, SVP and General Manager of Baymedica of InMed Pharmaceuticals (NASDAQ: INM), was a guest speaker at Benzinga’s All Access on June 17th, 2022. Via Benzinga CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Results of Peer-Reviewed Study Published in International Journal June 14, 2022 Via Investor Brand Network CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Results of Peer-Reviewed Study Published in International Journal June 14, 2022 Via CannabisNewsWire InMed Publishes Study On Potential Role Of Rare Cannabinoids For Skin Conditions June 14, 2022 InMed Pharmaceuticals Inc. (NASDAQ: INM) announced that a peer-reviewed scientific study entitled “Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes” has been... Via Benzinga BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Portfolio of Rare Cannabinoids with Launch of d9-THCV June 09, 2022 Via Investor Brand Network Topics Economy Supply Chain Exposures Supply Chain CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $5M Direct, Private Placement Offerings June 07, 2022 Via CannabisNewsWire CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $5M Direct, Private Placement Offerings June 07, 2022 Via Investor Brand Network CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces $5M Registered Direct and Private Placement Offerings June 02, 2022 Via CannabisNewsWire CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces $5M Registered Direct and Private Placement Offerings June 02, 2022 Via Investor Brand Network InMed Pharmaceuticals Announces $5 Million Registered Direct And Private Placement Offerings June 02, 2022 InMed Pharmaceuticals Inc. (NASDAQ: INM) has entered into securities purchase agreements with a single healthcare-focused institutional investor for the issuance and sale of 4.08 million of its common... Via Benzinga InMed Pharmaceuticals Is Commercializing The Development Of Rare Cannabinoids For The Wellness Market May 17, 2022 Upon its acquisition of BayMedica LLC last year, InMed Pharmaceuticals Inc. (Nasdaq: INM) made the executive decision to forge a new path alongside its traditional domain in pharmaceutical drug... Via Benzinga InMed Pharmaceuticals Reports Net Sales Of $575K For 6 Months Since BayMedica Acquisition May 13, 2022 InMed Pharmaceuticals Inc. (NASDAQ:INM), a leader in research, development, manufacturing and commercialization of rare cannabinoids, released unaudited financial results for the third quarter of the... Via Benzinga BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 Fiscal 2022 Financial Results, Provides Business Update May 13, 2022 Via Investor Brand Network Topics Economy Exposures Supply Chain CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space May 09, 2022 Via Investor Brand Network Topics Supply Chain Exposures Supply Chain CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space May 09, 2022 Via CannabisNewsWire Topics Supply Chain Exposures Supply Chain InMed Commercializes Rare Cannabinoids For Health And Wellness Market May 09, 2022 This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Participate in Groundbreaking Study with Trokie and Radicle Science May 05, 2022 Via Investor Brand Network BioMedNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Transition from Pure-Play Pharma R&D Firm Featured in Research Report May 04, 2022 Via Investor Brand Network Exposures Product Safety InMed Pharmaceuticals (INM): Notable Launches of High-Value Rare Cannabinoids May 03, 2022 Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. From Edison Investment Research Limited Via AccessWire Exposures Product Safety < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.